Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

JUPITER NEUROSCIENCES, INC. (JUNS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

JUPITER NEUROSCIENCES, INC. (JUNS), most recent 12 months reported: revenue $21.8K, net loss $9.2M. Latest balance sheet on file: liquid cash $1.52M, total debt $1.53M, net cash -$6.59K. From SEC filings. Others in Pharmaceutical Preparations: NEONC TECHNOLOGIES HOLDINGS, INC. · Impact BioMedical, INC. · Lyell Immunopharma, Inc. · BioAdaptives Inc. · Skinvisible, Inc. · PRF Technologies Ltd. · Aditxt, Inc. · GENELUX CORPORATION

Stock screener

Watchlist